Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Jun-24 6:10 AM View:  | Watson W. Mark Director | Nabi Biopharmaceuticals (VXRT) | 18-Jun-24 | Private Purchase | 20,000 | $0.68 | $13,578.00 | 34% 58.13K to 78.13K | |
| 13-Jun-24 4:36 PM View: | Lee Phillip E Chief Financial Officer | Nabi Biopharmaceuticals (VXRT) | 12-Jun-24 | Payment of Exercise | 2,007 | $0.76 | $1,525.32 | (< 1%) 241.81K to 239.8K | |
| 12-Jun-24 4:38 PM View: | Yedid Robert A. Director | Nabi Biopharmaceuticals (VXRT) | 11-Jun-24 | Grant | 16,000 | -- | -- | 87% 18.49K to 34.49K | |
| 12-Jun-24 4:40 PM View: | Finney Michael J. Director | Nabi Biopharmaceuticals (VXRT) | 11-Jun-24 | Grant | 16,000 | -- | -- | 2% 670.84K to 686.84K | |
| 12-Jun-24 4:39 PM View: | Watson W. Mark Director | Nabi Biopharmaceuticals (VXRT) | 11-Jun-24 | Grant | 16,000 | -- | -- | 38% 42.13K to 58.13K | |
| 12-Jun-24 4:40 PM View: | Wheadon David E. Director | Nabi Biopharmaceuticals (VXRT) | 11-Jun-24 | Grant | 16,000 | -- | -- | 108% 14.75K to 30.75K | |
| 12-Jun-24 4:39 PM View: | Heron Elaine J Director | Nabi Biopharmaceuticals (VXRT) | 11-Jun-24 | Grant | 16,000 | -- | -- | 65% 24.57K to 40.57K | |
| 01-Apr-24 7:16 PM View: | Tucker Sean SVP, Chief Scientific Officer | Nabi Biopharmaceuticals (VXRT) | 28-Mar-24 | Payment of Exercise | 3,902 | $1.30 | $5,072.60 | (< 1%) 420.12K to 416.22K | |
| 01-Apr-24 7:13 PM View: | Cummings James F. Chief Medical Officer | Nabi Biopharmaceuticals (VXRT) | 28-Mar-24 | Payment of Exercise | 3,292 | $1.30 | $4,279.60 | (< 1%) 330.09K to 326.8K | |
| 20-Mar-24 8:07 PM View: | Berg Edward B SVP, General Counsel | Nabi Biopharmaceuticals (VXRT) | 18-Mar-24 | Grant | 90,000 | -- | -- | 50% 180.71K to 270.71K | |
| 20-Mar-24 8:10 PM View: | Lee Phillip E Chief Financial Officer | Nabi Biopharmaceuticals (VXRT) | 18-Mar-24 | Grant | 90,000 | -- | -- | 59% 151.81K to 241.81K | |
| 20-Mar-24 8:09 PM View: | Cummings James F. Chief Medical Officer | Nabi Biopharmaceuticals (VXRT) | 18-Mar-24 | Grant | 90,000 | -- | -- | 37% 240.09K to 330.09K | |
| 20-Mar-24 8:12 PM View: | Tucker Sean SVP, Chief Scientific Officer | Nabi Biopharmaceuticals (VXRT) | 18-Mar-24 | Grant | 90,000 | -- | -- | 27% 330.12K to 420.12K | |
| 20-Mar-24 8:03 PM View: | Lo Steven President, Chief Exec Officer Director | Nabi Biopharmaceuticals (VXRT) | 18-Mar-24 | Grant | 250,000 | -- | -- | 100% 0 to 250.0K | |
| 20-Mar-24 8:09 PM View: | Cummings James F. Chief Medical Officer | Nabi Biopharmaceuticals (VXRT) | 02-Feb-24 | Payment of Exercise | 7,965 | $1.20 | $9,558.00 | (3%) 248.06K to 240.09K | |
| 20-Mar-24 8:12 PM View: | Tucker Sean SVP, Chief Scientific Officer | Nabi Biopharmaceuticals (VXRT) | 02-Feb-24 | Payment of Exercise | 9,220 | $1.20 | $11,064.00 | (3%) 339.34K to 330.12K | |
| 20-Mar-24 8:07 PM View: | Berg Edward B SVP, General Counsel | Nabi Biopharmaceuticals (VXRT) | 02-Feb-24 | Payment of Exercise | 9,220 | $1.20 | $11,064.00 | (5%) 189.93K to 180.71K | |
| 20-Mar-24 8:10 PM View: | Lee Phillip E Chief Financial Officer | Nabi Biopharmaceuticals (VXRT) | 15-Dec-23 | Payment of Exercise | 5,943 | $0.63 | $3,744.09 | (4%) 157.75K to 151.81K | |
| 20-Mar-24 8:12 PM View: | Tucker Sean SVP, Chief Scientific Officer | Nabi Biopharmaceuticals (VXRT) | 08-Dec-23 | Payment of Exercise | 34,288 | $0.71 | $24,344.50 | (9%) 373.63K to 339.34K | |
| 20-Mar-24 8:07 PM View: | Berg Edward B SVP, General Counsel | Nabi Biopharmaceuticals (VXRT) | 08-Dec-23 | Payment of Exercise | 33,752 | $0.71 | $23,963.90 | (15%) 223.68K to 189.93K | |
| 20-Mar-24 8:10 PM View: | Lee Phillip E Chief Financial Officer | Nabi Biopharmaceuticals (VXRT) | 08-Dec-23 | Payment of Exercise | 35,151 | $0.71 | $24,957.20 | (18%) 192.9K to 157.75K | |
| 20-Mar-24 8:09 PM View: | Cummings James F. Chief Medical Officer | Nabi Biopharmaceuticals (VXRT) | 08-Dec-23 | Payment of Exercise | 31,409 | $0.71 | $22,300.40 | (11%) 279.47K to 248.06K | |
| 01-Aug-23 8:49 PM View: | Finney Michael J. Director | Nabi Biopharmaceuticals (VXRT) | 26-Jun-23 | Grant | 7,375 | -- | -- | 1% 663.47K to 670.84K | |
| 01-Aug-23 9:14 PM View: | Wheadon David E. Director | Nabi Biopharmaceuticals (VXRT) | 26-Jun-23 | Grant | 7,375 | -- | -- | 100% 7.38K to 14.75K | |
| 01-Aug-23 9:20 PM View: | Heron Elaine J Director | Nabi Biopharmaceuticals (VXRT) | 26-Jun-23 | Grant | 6,922 | -- | -- | 39% 17.64K to 24.57K | |
| 01-Aug-23 9:16 PM View: | Yedid Robert A. Director | Nabi Biopharmaceuticals (VXRT) | 26-Jun-23 | Grant | 7,375 | -- | -- | 66% 11.12K to 18.49K | |
| 01-Aug-23 9:23 PM View: | Watson W. Mark Director | Nabi Biopharmaceuticals (VXRT) | 26-Jun-23 | Grant | 7,375 | -- | -- | 21% 34.75K to 42.13K | |
| 14-Jun-23 9:02 PM View: | Lee Phillip E Chief Financial Officer | Nabi Biopharmaceuticals (VXRT) | 12-Jun-23 | Grant | 22,500 | -- | -- | 13% 170.4K to 192.9K | |
| 20-Mar-24 8:12 PM View: | Tucker Sean SVP, Chief Scientific Officer | Nabi Biopharmaceuticals (VXRT) | 28-Mar-23 | Payment of Exercise | 3,683 | $0.75 | $2,762.25 | (< 1%) 377.31K to 373.63K | |
| 21-Mar-23 7:53 PM View: | Cummings James F. Chief Medical Officer | Nabi Biopharmaceuticals (VXRT) | 17-Mar-23 | Grant | 194,350 | -- | -- | 444% 43.75K to 238.1K | |
| 21-Mar-23 7:54 PM View: | Tucker Sean SVP, Chief Scientific Officer | Nabi Biopharmaceuticals (VXRT) | 17-Mar-23 | Grant | 189,157 | -- | -- | 101% 188.16K to 377.31K | |
| 21-Mar-23 8:06 PM View: | Floroiu Cezar Andrei President, Chief Exec Officer Director | Nabi Biopharmaceuticals (VXRT) | 17-Mar-23 | Grant | 367,735 | -- | -- | 433% 85.0K to 452.74K | |
| 21-Mar-23 7:54 PM View: | Lee Phillip E Chief Financial Officer | Nabi Biopharmaceuticals (VXRT) | 17-Mar-23 | Grant | 191,652 | -- | -- | 279% 68.75K to 260.4K | |
| 21-Mar-23 8:06 PM View: | Berg Edward B SVP, General Counsel | Nabi Biopharmaceuticals (VXRT) | 17-Mar-23 | Grant | 187,606 | -- | -- | 100% 0 to 187.61K | |
| 28-Dec-22 5:25 PM View: | Watson W. Mark Director | Nabi Biopharmaceuticals (VXRT) | 28-Dec-22 | Private Purchase | 20,000 | $0.76 | $15,140.00 | 100% 0 to 20.0K | |
| 30-Dec-22 8:21 PM View: | Lee Phillip E Chief Financial Officer | Nabi Biopharmaceuticals (VXRT) | 16-Dec-22 | Grant | 68,750 | -- | -- | 100% 0 to 68.75K | |
| 25-Aug-22 5:06 PM View: | Heron Elaine J Director | Nabi Biopharmaceuticals (VXRT) | 25-Aug-22 | Grant | 14,750 | -- | -- | 510% 2.89K to 17.64K | |
| 26-Aug-22 3:46 PM View: | Yedid Robert A. Director | Nabi Biopharmaceuticals (VXRT) | 24-Aug-22 | Gift | 26,240 | -- | -- | (70%) 37.35K to 11.12K | |
| 22-Aug-22 6:06 PM View: | Yedid Robert A. Director | Nabi Biopharmaceuticals (VXRT) | 19-Aug-22 | Option Exercise | 26,240 | $0.94 | $24,774.40 | 208% 12.62K to 38.85K | |
| 08-Aug-22 6:26 PM View: | Davis Todd C Director | Nabi Biopharmaceuticals (VXRT) | 04-Aug-22 | Grant | 7,375 | -- | -- | 6% 118.53K to 125.91K | |
| 08-Aug-22 6:36 PM View: | Yedid Robert A. Director | Nabi Biopharmaceuticals (VXRT) | 04-Aug-22 | Grant | 7,375 | -- | -- | 141% 5.24K to 12.62K | |
| 08-Aug-22 6:34 PM View: | Wheadon David E. Director | Nabi Biopharmaceuticals (VXRT) | 04-Aug-22 | Grant | 7,375 | -- | -- | 100% 0 to 7.38K | |
| 08-Aug-22 6:22 PM View: | Cherrington Julie M Director | Nabi Biopharmaceuticals (VXRT) | 04-Aug-22 | Grant | 6,217 | -- | -- | 100% 0 to 6.22K | |
| 08-Aug-22 6:39 PM View: | Watson W. Mark Director | Nabi Biopharmaceuticals (VXRT) | 04-Aug-22 | Grant | 14,750 | -- | -- | 100% 0 to 14.75K | |
| 08-Aug-22 6:31 PM View: | Finney Michael J. Director | Nabi Biopharmaceuticals (VXRT) | 04-Aug-22 | Grant | 7,375 | -- | -- | 1% 656.09K to 663.47K | |
| 23-Jun-22 4:32 PM View: | Ahmad Fuad Interim CFO | Nabi Biopharmaceuticals (VXRT) | 22-Jun-22 | Private Purchase | 5,000 | $3.22 | $16,100.00 | 100% 0 to 5.0K | |
| 25-Apr-22 4:40 PM View: | Tucker Sean SVP, Chief Scientific Officer | Nabi Biopharmaceuticals (VXRT) | 22-Apr-22 | Option Exercise | 40,000 | $0.77 | $30,800.00 | 27% 148.16K to 188.16K | |
| 30-Mar-22 9:19 PM View: | Tucker Sean SVP, Chief Scientific Officer | Nabi Biopharmaceuticals (VXRT) | 28-Mar-22 | Grant | 43,750 | -- | -- | 42% 104.41K to 148.16K | |
| 30-Mar-22 9:20 PM View: | Floroiu Cezar Andrei President, Chief Exec Officer Director | Nabi Biopharmaceuticals (VXRT) | 28-Mar-22 | Grant | 85,000 | -- | -- | 100% 0 to 85.0K | |
| 30-Mar-22 9:24 PM View: | Cummings James F. Chief Medical Officer | Nabi Biopharmaceuticals (VXRT) | 28-Mar-22 | Grant | 43,750 | -- | -- | 100% 0 to 43.75K |
